IM Cannabis Corp. - Common Shares (IMCC)
2.2100
-0.0300 (-1.34%)
IM Cannabis Corp is a leading vertically integrated cannabis company that specializes in the cultivation, production, and distribution of medical and recreational cannabis products
Based in Canada and with operations extending into international markets, the company focuses on providing high-quality cannabis to consumers while adhering to regulatory standards. IM Cannabis prioritizes innovation and sustainability in its cultivation practices and offers a diverse range of products, including dried flower, oils, and infused edibles, all aimed at enhancing the wellness and lifestyle of its customers. Through strategic partnerships and an expanding global footprint, the company aims to become a key player in the evolving cannabis industry.
Breaking on The Street Stocks To Watch Now! CTMX, PRSO, IMCC, KAVL, VTAK
Investors are eyeing numerous companies lately, and here's an insight into five of them.
Via AB Newswire · May 3, 2024
Avant Brands Bolsters International Growth in German Cannabis Market Through Partnership with IMC
KELOWNA, BC, TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / April 4, 2024 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products and IM Cannabis Corp. (CSE:IMCC)(NASDAQIMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, are pleased to announce the signing of an International Trademark Licensing Agreement (the "Licensing Agreement") granting IMC's German subsidiary, Adjupharm GmbH ("Adjupharm"), the exclusive right to launch Avant's flagship brand, BLK MKT™ brand in the German cannabis market. The Licensing Agreement constitutes a significant expansion of the relationship between the two industry-leading cannabis companies.
Via ACCESSWIRE · April 4, 2024
Avant Brands and IM Cannabis Announce the Launch of BLK MKT in Israel
KELOWNA, BC and GLIL YAM, ISRAEL / ACCESSWIRE / October 12, 2022 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company") and IM Cannabis Corp. ("IMC") (CSE:IMCC)(NASDAQIMCC), jointly announce the signing of an international trademark licensing agreement (the "Licensing Agreement") granting IMC the exclusive right to launch the BLKMKT brand in the Israeli medical cannabis market. The Licensing Agreement constitutes a significant milestone in the maturing and mutually beneficial relationship between the two premium cannabis companies in the Canadian and Israeli medical cannabis markets.
Via ACCESSWIRE · October 12, 2022
IM Cannabis announces Focus Medical's Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel
The successful import demonstrates the strength of the IM Cannabis global supply chain and business model TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / January 19, 2022 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC)(NASDAQIMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany is pleased to announce that Focus Medical Herbs Ltd. ("Focus Medical") has completed the
By IM Cannabis Corp. · Via AccessWire · January 19, 2022
IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company’s Israeli Subsidiary
Oren Shuster remains Chief Executive Officer and Director of IM Cannabis Corp.; other managerial changes include the promotion of Yael Harrosh to Chief Legal and Operations Officer of IM Cannabis Corp. TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / January 13, 2022 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC)(NASDAQIMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and
By IM Cannabis Corp. · Via AccessWire · January 13, 2022
IM Cannabis to Launch WAGNERS Brand in Germany
IM Cannabis expects to export premium, indoor-grown Canadian cannabis in 2022 to the rapidly evolving German medical cannabis market TORONTO, ON, GLIL YAM, ISRAEL and BAD OLDESLOE, GERMANY / ACCESSWIRE / December 7, 2021 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC, NASDAQ:IMCC), a global cannabis company with operations in Israel, Canada, and Germany is pleased to announce plans to launch its popular Canadian WAGNERS brand in
By IM Cannabis Corp. · Via AccessWire · December 7, 2021
IM Cannabis to Acquire Oranim, Jerusalem's Leading Medical Cannabis Pharmacy
Transaction positions IM Cannabis as one of the largest retailers of medical cannabis in Israel; Retail segment combined annualized revenue of approximately $44 million Oranim's trailing 12-month revenue approximately $16.5 million and gross margin approximately 25%[1] before recognizing synergies TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / December 1, 2021 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC), (NASDAQIMCC), a
By IM Cannabis Corp. · Via AccessWire · December 1, 2021
IM Cannabis Announces Focus Medical's Receipt of Israeli Ministry of Health Import Permit; Plans to Launch WAGNERS Brand in Israel
IM Cannabis' popular recreational cannabis brand WAGNERS will be available in Israel in 2022, enhancing IM Cannabis' presence in the market TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / November 29, 2021 / IM Cannabis Corp . (the "Company" or "IM Cannabis") (CSE:IMCC)(NASDAQIMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany is pleased to announce that on November 28, 2021, Focus
By IM Cannabis Corp. · Via AccessWire · November 29, 2021
IM Cannabis Announces Fourth Installment of Shares in Connection with the Panaxia Transaction
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / November 18, 2021 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC)(NASDAQIMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Germany and Canada, today announced the fourth installment of shares in connection with the previously announced acquisition of the Panaxia-to-the-Home online pharmacy and trading centre with an IMC-GDP license from
By IM Cannabis Corp. · Via AccessWire · November 18, 2021
IM Cannabis Announces Third Quarter 2021 Financial Results and Provides Outlook and Business Update
Q3 2021 revenues of $14.4 million; a 30% increase from Q2 2021 Gross margin improved to 20% from 5.4% in Q2 2021; expected to increase further in Q4 and into 2022 Canadian recreational brands WAGNERS and Highland Grow continue to gain market share, with sales in Ontario from June to October increasing by over 110% TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / November 15, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC),
By IM Cannabis Corp. · Via AccessWire · November 15, 2021
IMC Announces Third Installment of Shares in Connection with the Panaxia Transaction
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / October 20, 2021 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC, NASDAQ:IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Germany and Canada, today announced the third installment of shares in connection with the previously announced acquisition of the Panaxia-to-the-Home online pharmacy and trading center with an IMC-GDP license from
By IM Cannabis Corp. · Via AccessWire · October 20, 2021
IMC Provides Further Details on Panaxia Transaction
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / September 8, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQIMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, provides details of the shares issued as part of the share consideration paid in connection with the previously announced acquisition of the Panaxia-to-the-Home online
By IM Cannabis Corp. · Via AccessWire · September 8, 2021
IM Cannabis Announces Q2 2021 Financial Results and Signing of Definitive Agreement to Acquire Vironna Pharm, Accelerating its Vertical Integration Strategy in Israel
Q2 2021 revenues of $11.1 million, a 27% increase from Q1 2021 Acquisition of Vironna pharmacy positions IMC in rapidly growing Arab consumer segment in Israel Following strong start to Q3 across each of its geographic segments, IMC expects significant revenue growth this quarter TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / August 16, 2021 / IM Cannabis Corp. (" IMC " or the " Company ") (CSE:IMCC), (NASDAQIMCC), a multi-country operator
By IM Cannabis Corp. · Via AccessWire · August 16, 2021
IMC Partners with Leading US Brand to Launch cbdMD Products in Israel and Provides Further Details on Panaxia Transaction
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / August 9, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC, NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the signing of a binding letter of intent (the "Binding LOI") with cbdMD, Inc. (YCBD, YCBDpA), one of the leading and most highly trusted and recognized CBD
By IM Cannabis Corp. · Via AccessWire · August 9, 2021
IMC Announces Results of its Annual General and Special Meeting of Shareholders
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / August 3, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC), (NASDAQIMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the voting results from its annual general and special meeting of shareholders held on Wednesday July 28, 2021 (the "Meeting"). A total of 37,108,584
By IM Cannabis Corp. · Via AccessWire · August 3, 2021
IMC Accelerates its Israeli Retail Position through Acquisition of Leading Retailer and Distributor Pharm Yarok and Rosen High Way
- Strategically located, best in class retailer with approximately CAD$8 million in annualized revenue - Purchase price of CAD$4.6 million TORONTO, ON, GLIL YAM and NATANYA, ISRAEL / ACCESSWIRE / July 28, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC, NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the
By IM Cannabis Corp. · Via AccessWire · July 28, 2021
IM Cannabis Provides Update on German Operations and Financial Outlook
TORONTO, ON, BAD OLDESLOE, GERMANY, and GLIL YAM, ISRAEL / ACCESSWIRE / July 23, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQIMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, announces the completion of a new, state-of-the-art logistics centre in Germany (the "Logistics Centre") that will allow Adjupharm GmbH ("Adjupharm"), the
By IM Cannabis Corp. · Via AccessWire · July 23, 2021
IM Cannabis Provides Business, Legal and Regulatory Update
- IMC subsidiary, Adjupharm, to expand German product portfolio with unique strains via supply agreements with The Green Organic Dutchman and Natural MedCo - German Brand Institute awards IMC with the "German Brand Award 2021" for the Company's successful market launch campaign - Israeli Ministerial Committee on Legislative Affairs approves bill for legalization of CBD and decriminalization of cannabis consumers on July 11th TORONTO, ON, BAD
By IM Cannabis Corp. · Via AccessWire · July 13, 2021
IM Cannabis Closes Acquisition of MYM Nutraceuticals
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / July 9, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (NASDAQIMCC)(CSE:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sectors with operations in Israel, Germany and Canada, and MYM Nutraceuticals Inc. ("MYM"), a Canadian cultivator, processor, and distributor of premium cannabis, are pleased to announce, further to IMC's press release on July 6, 2021,
By IM Cannabis Corp. · Via AccessWire · July 9, 2021
MYM Shareholders Overwhelmingly Approve Plan of Arrangement with IM Cannabis
Highland Grow is currently profitable on an EBITDA basis, unlocks margin expansion and is expected to be immediately accretive to IM Cannabis Super premium positioning, complementary brands, enhanced distribution and export opportunities provide compelling strategic rationale Closing is expected on or around July 9, 2021 TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / July 6, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (NASDAQIMCC)
By IM Cannabis Corp. · Via AccessWire · July 6, 2021
IM Cannabis Proposed Acquisition of MYM Receives Positive Recommendations from Proxy Advisory Firms Glass Lewis and ISS
Glass Lewis and Institutional Shareholder Services recommend that MYM shareholders vote FOR Transaction with IMCC Over 90% of committed and tallied common shares are being voted in favor of the Transaction TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / June 28, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (NASDAQIMCC)(CSE:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sectors with operations in
By IM Cannabis Corp. · Via AccessWire · June 28, 2021
IM Cannabis Clinical Survey Confirms Effectiveness of Proprietary Strains in Alleviating Symptoms of Seven Key Health Conditions
Conditions Evaluated Include Oncology, PTSD, Rheumatoid Arthritis, Chronic Pain, Insomnia, Back Pain and Inflammatory Bowel Diseases Conducted by Leading Contract Research Organization for Cannabis Research, Survey Covered More Than 650 Patients Using FDA-Validated Questionnaires TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / June 17, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC, CSE:IMCC), a multi-country operator ("MCO") in
By IM Cannabis Corp. · Via AccessWire · June 17, 2021
Q2 2021’s Cannabis Stock Advances and Declines So Far
FN Media Presents Rotten Tomato Stocks Commentary
Via FinancialNewsMedia · June 9, 2021
IM Cannabis Announces Supply Agreement with Canadian LP The Flowr Corporation; Plan to Import Ultra-Premium Products as part of Enhanced Portfolio to Meet Growing Israeli Demand
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / June 7, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC) (NASDAQIMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce that Focus Medical Herbs Ltd. ("Focus Medical") has signed a multi-year supply agreement with The Flowr Corporation ("Flowr") (TSX.V:FLWR, OTC:FLWPF), a
By IM Cannabis Corp. · Via AccessWire · June 7, 2021
IMC Reports First Closing of the Panaxia Acquisition and Provides Update on Canadian Business Activities
Launches WAGNERS brand with new cultivars and SKUs MYM shareholder meeting set for July 5, 2021 Substantially completes loan portfolio run-off and realizes a 24% IRR TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / June 1, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC), (NASDAQIMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations
By IM Cannabis Corp. · Via AccessWire · June 1, 2021